Australia markets closed

Mainz Biomed N.V. (MYNZ)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7630-0.0230 (-3.05%)
As of 01:45PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 16.75M
Enterprise value 17.10M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)13.88
Price/book (mrq)5.15
Enterprise value/revenue 19.09
Enterprise value/EBITDA -0.69

Trading information

Stock price history

Beta (5Y monthly) 0.24
52-week change 3-84.79%
S&P500 52-week change 322.43%
52-week high 36.0000
52-week low 30.7200
50-day moving average 30.9682
200-day moving average 31.8999

Share statistics

Avg vol (3-month) 3106.02k
Avg vol (10-day) 3239.18k
Shares outstanding 521.89M
Implied shares outstanding 621.89M
Float 818.39M
% held by insiders 121.63%
% held by institutions 11.06%
Shares short (15 Apr 2024) 4301.54k
Short ratio (15 Apr 2024) 45.38
Short % of float (15 Apr 2024) 41.64%
Short % of shares outstanding (15 Apr 2024) 41.38%
Shares short (prior month 15 Mar 2024) 4317.05k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,068.71%

Management effectiveness

Return on assets (ttm)-93.42%
Return on equity (ttm)-303.20%

Income statement

Revenue (ttm)895.48k
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)11.10%
Gross profit (ttm)N/A
EBITDA -26.07M
Net income avi to common (ttm)-26.3M
Diluted EPS (ttm)-1.6200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.07M
Total cash per share (mrq)0.32
Total debt (mrq)7.42M
Total debt/equity (mrq)228.39%
Current ratio (mrq)0.97
Book value per share (mrq)0.15

Cash flow statement

Operating cash flow (ttm)-21.94M
Levered free cash flow (ttm)-13.61M